|
|
| Name | Last | Chg |
|---|---|---|
| Dow Jones | 38675.68 |  1.18%
|
| NASDAQ | 16156.33 | 1.99%
|
All information above is at least 15 mins delayed.
Enter Symbol
|
|
| Name | Last | Chg |
|---|---|---|
| Dow Jones | 38675.68 | 1.18%
|
| NASDAQ | 16156.33 | 1.99%
|
| Symbol | Last | Chg |
|---|---|---|
| BENF | 6.8200 |
255.21%
|
| SGBX | 5.5400 |
89.08%
|
| AIP | 8.2100 |
38.45%
|
| LUNA | 3.0600 |
36.00%
|
| KOSS | 3.1000 |
29.71%
|
| Symbol | Last | Chg |
|---|---|---|
| MNDR | 3.3900 |
84.64%
|
| NUVO | 2.0400 |
56.69%
|
| SPT | 28.8200 |
40.15%
|
| UNIT | 4.4400 |
26.37%
|
| CRDF | 3.5200 |
21.43%
|
| Symbol | Last | Chg |
|---|---|---|
| AAPL | 183.3800 |
5.98%
|
| SQQQ | 11.0800 |
5.94%
|
| JAGX | 0.3180 |
8.46%
|
| NKLA | 0.6575 |
7.35%
|
| SGBX | 5.5400 |
89.08%
|
LOS ANGELES, CA / ACCESSWIRE / April 25, 2024 / The Schall Law Firm, a
national shareholder rights litigation firm, reminds investors of a class
action lawsuit against Ocugen, Inc. ("Ocugen" or "the Company") (NASDAQ:OCGN)
for for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934
and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
Commission.
Investors who purchased the Company's securities between May 8, 2020 and April
1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm
before June 10, 2024.
If you are a shareholder who suffered a loss, click here to participate.
(https://pr.report/M3ietIkL)
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049
Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to
discuss your rights free of charge. You can also reach us through the firm's
website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification
occurs, you are not represented by an attorney. If you choose to take no
action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements
to the market. Ocugen materially misstated its financial statements from May
8, 2020, to recent periods. The Company failed to maintain appropriate
controls on financial reporting. Based on these facts, the Company's public
statements were false and materially misleading throughout the class period.
When the market learned the truth about Ocugen, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in
securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
SOURCE: The Schall Law Firm
View the original press release
(https://www.accesswire.com/856623/deadline-action-alert-the-schall-law-firm-encourages-investors-in-ocugen-inc-with-losses-to-contact-the-firm)
on accesswire.com
Copyright 2024 ACCESSWIRE. All Rights Reserved.